ReviewFrontiers in oncology2019

Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.

Alessandra Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.